Myriad Genetics Inc (NASDAQ:MYGN)

25.20
Delayed Data
As of May 20
 -0.80 / -3.08%
Today’s Change
25.19
Today|||52-Week Range
50.44
-13.31%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Capone Mark C
President & Chief Executive Officer
Sale5/30/201890,000$38.00$3.4M-31.39%
Capone Mark C
President & Chief Executive Officer
Sale7/11/201877,654$41.00$3.2M-41.45%
Capone Mark C
President & Chief Executive Officer
Buy7/11/201877,654$30.12$2.3M-41.45%
Lanchbury Jerry S
Chief Scientific Officer
Sale6/18/201857,654$40.12$2.3M-37.27%
Capone Mark C
President & Chief Executive Officer
Buy5/30/201890,000$22.93$2.1M-31.39%
Lanchbury Jerry S
Chief Scientific Officer
Sale7/11/201846,139$43.34$2.0M-41.45%
Lanchbury Jerry S
Chief Scientific Officer
Buy6/18/201857,654$30.12$1.7M-37.27%
Marsh Richard M
Executive Vice President & General Counsel
Sale7/11/201840,000$42.02$1.7M-41.45%
Lanchbury Jerry S
Chief Scientific Officer
Buy7/11/201846,139$30.34$1.4M-41.45%
Marsh Richard M
Executive Vice President & General Counsel
Sale7/11/201830,672$44.00$1.3M-41.45%
Page of 11